CD86 and inflammatory bowel disease: In IBD, activated B cells could exacerbate proinflammatory cytokine production by intestinal CD4+ T cells through the co-stimulating factor CD40L-CD86, and depletion of B cells diminished intestinal inflammation due to reduced CD4+ T cell proinflammatory cytokine production [30].